Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 26Small Cell Lung Carcinoma 22Neuroblastoma 12Fallopian Tube Neoplasms 12Uterine Cervical Neoplasms 8Carcinoma, Ovarian Epithelial 8Lung Neoplasms 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 4Leukemia, Myeloid, Acute 3Ganglioneuroblastoma 3Brain Neoplasms 3Sarcoma 2Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Carcinoma, Neuroendocrine 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Rhabdoid Tumor 1Retinoblastoma 1Retinal Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Localized Extraskeletal Ewing Sarcoma × Topotecan × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡